Healthcare analysts shed light on vaccine maker Novavax, Inc. (NASDAQ:NVAX), and Israeli biotech firm Can-Fite Biopharma Ltd (NYSE:CANF).
McDonald’s Corporation (NYSE:MCD) is up 6.50% in pre-market trading to $109.
Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Can-Fite BioPharma (NYSE:CANF) with a $20 price target, which implies an upside of 402% …
In a research report issued yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Can-Fite BioPharma (NYSE:CANF) with a price target …